• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aclaris Therapeutics, Inc. - Common Stock (NQ:ACRS)

3.470 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 87
Open 3.470
Bid (Size) 3.420 (4,500)
Ask (Size) 3.760 (300)
Prev. Close 3.470
Today's Range 3.470 - 3.470
52wk Range 1.050 - 4.890
Shares Outstanding 107,850,124
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround ↗
February 03, 2026
CarMax runs a nationwide network of used car stores and digital channels, offering multi-channel sales and financing to U.S. consumers. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter. ↗
February 03, 2026
This clinical-stage biotech develops therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition. 
Via The Motley Fool

Performance

YTD
+20.5%
+20.5%
1 Month
+30.9%
+30.9%
3 Month
+47.0%
+47.0%
6 Month
+123.9%
+123.9%
1 Year
+44.6%
+44.6%

More News

Read More
Here are the top movers in Tuesday's session. ↗
January 20, 2026
Via Chartmill
Tuesday's session: top gainers and losers ↗
January 20, 2026
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
January 20, 2026
Via Chartmill
News headline image
Stock Market Today: US Future Edge Higher Ahead Of FOMC Decision—Meta, Microsoft Earnings In Focus ↗
July 30, 2025
Via Benzinga
News headline image
Aclaris Therapeutics Stock Spikes In After‑Hours Session Following Major Announcement ↗
July 30, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
July 29, 2025
Via Benzinga
News headline image
What's going on in today's after hours session ↗
July 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
May 28, 2025
Via Benzinga
News headline image
This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
May 28, 2025
Via Benzinga
News headline image
Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy ↗
December 23, 2024
Via Benzinga
News headline image
Santa Rally, January Effect, And Top Stock Picks ↗
December 23, 2024
Via Talk Markets
Topics Stocks / Equities
News headline image
This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday ↗
December 23, 2024
Via Benzinga
News headline image
Level Up Your Trading: Inside The 4-Pillar Strategy Behind Triple-Digit Returns ↗
December 18, 2024
Via Talk Markets
Topics Stocks / Equities
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
November 19, 2024
Via Benzinga
News headline image
Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments ↗
November 19, 2024
Via Benzinga
News headline image
War, Gold, And Opportunity: Uncovering Today’s Market Moves ↗
November 19, 2024
Via Talk Markets
News headline image
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗
November 19, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
October 28, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 25, 2024
Via Benzinga
News headline image
Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying ↗
July 23, 2024
Via Benzinga
News headline image
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
July 11, 2024
Via MarketBeat
News headline image
Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying ↗
July 08, 2024
Via Benzinga
News headline image
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗
June 14, 2024
Via Benzinga

Frequently Asked Questions

Is Aclaris Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aclaris Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aclaris Therapeutics, Inc. - Common Stock trade on?
Aclaris Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aclaris Therapeutics, Inc. - Common Stock?
The ticker symbol for Aclaris Therapeutics, Inc. - Common Stock is ACRS on the Nasdaq Stock Market
What is the current price of Aclaris Therapeutics, Inc. - Common Stock?
The current price of Aclaris Therapeutics, Inc. - Common Stock is 3.470
When was Aclaris Therapeutics, Inc. - Common Stock last traded?
The last trade of Aclaris Therapeutics, Inc. - Common Stock was at 02/03/26 04:00 PM ET
What is the market capitalization of Aclaris Therapeutics, Inc. - Common Stock?
The market capitalization of Aclaris Therapeutics, Inc. - Common Stock is 374.24M
How many shares of Aclaris Therapeutics, Inc. - Common Stock are outstanding?
Aclaris Therapeutics, Inc. - Common Stock has 374M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap